HealthEquity (HQY) vs Heartflow (HTFL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Heartflow (HTFL) has outperformed HealthEquity (HQY) over the past year, gaining 33.2% versus a loss of 0.2%. HealthEquity is the larger company by market cap ($7.66 billion vs $4.33 billion), about 1.8 times the size, while Heartflow is growing revenue faster (+39.9% vs +9.5%). HealthEquity converts more of its revenue into profit, with a net margin of 16.4% versus -66.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQY | HTFL |
|---|---|---|
| Share price | $92.61 | $49.74 |
| Market cap | $7.66B | $4.33B |
| 1-day change | -0.47% | +4.43% |
| YTD return | +1.09% | +63.40% |
| 1-year return | -0.18% | +33.19% |
| 5-year return | +47.35% | — |
| P/E ratio (TTM) | 33.43 | — |
| Forward P/E | 16.84 | — |
| EPS (TTM) | $2.77 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.31B | $176.03M |
| Revenue growth (YoY) | +9.47% | +39.92% |
| Net income (latest FY) | $215.20M | $-116.79M |
| Gross margin | 69.52% | 76.80% |
| Operating margin | 24.55% | -36.39% |
| Net margin | 16.38% | -66.35% |
| 52-week high | $107.62 | $54.32 |
| 52-week low | $72.76 | $20.13 |
| Distance from 52-week high | -13.95% | -8.43% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +28.85% | -7.52% |
| Average volume | 844.82K | 1.81M |
| Shares outstanding | 82.72M | 86.95M |
| Employees | 2,814 | 843 |
| Sector | Consumer Discretionary | Health Care |
| Industry | Business Services | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HTFL has outperformed HQY by 33.4 percentage points over the past year.
- HealthEquity is more profitable, keeping 16.4 cents of every revenue dollar as net income versus -66.3 cents for Heartflow.
- Heartflow grew revenue faster in its latest fiscal year (+39.92% vs +9.47%).
- The two companies sit in different sectors: HealthEquity in Consumer Discretionary and Heartflow in Health Care.
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
About Heartflow
HTFL stock →HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Health Care · Medical/Dental Instruments · 843 employees
HQY vs HTFL FAQ
Which is bigger, HealthEquity or Heartflow?
HealthEquity (HQY) is larger, with a market capitalization of $7.66B compared with $4.33B for Heartflow (HTFL).
Which stock has performed better over the past year, HQY or HTFL?
HTFL returned +33.19% over the past 12 months, compared with -0.18% for HQY (price return, excluding dividends). Past performance does not predict future results.
Are HealthEquity and Heartflow in the same industry?
No. HealthEquity is in the Consumer Discretionary sector, while Heartflow is in Health Care.